Suppr超能文献

伴有血栓形成表现的纤维蛋白原缺乏症

Fibrinogen Deficiency with Thrombotic Manifestations.

作者信息

Tamayo-Velasco Álvaro, Cebeira María José, Bombín-Canal Carolina, Acevedo-García Rosa María, Peñarrubia-Ponce María Jesús

机构信息

Haematology and Haemotherapy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

BioCritic - Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.

出版信息

Eur J Case Rep Intern Med. 2022 Jun 28;9(6):003400. doi: 10.12890/2022_003400. eCollection 2022.

Abstract

UNLABELLED

Fibrinogen deficiencies are very rare. Qualitative fibrinogen deficiencies (dysfibrinogenaemia and hypodysfibrinogenemia) are functional disorders that can present with both haemorrhagic symptoms and with thrombotic phenomena as unique and paradoxical manifestation. We present the case of a 77-year-old man being investigated for a partially thrombosed abdominal aortic aneurysm as well as an ischaemic stroke 20 years previously. Basic coagulation tests were normal but extended tests revealed a lengthened thrombin time (TT) combined with a significant drop in fibrinogen concentration measured with the Clauss assay and by nephelometry. After secondary fibrinogen deficiencies were ruled out, a heterozygous variant in the FGG gene was detected by next-generation sequencing, and congenital hypodysfibrinogenemia was diagnosed. Acenocumarol was initiated and no new thrombotic or haemorrhagic events had occurred after a year of follow-up. In almost 25% of cases, thrombotic events may be the only clinical manifestation of functional fibrinogen deficiencies. They are a rare cause of thrombophilia, and are probably underdiagnosed due to normal standard coagulation test results as well as a possible absence of haemorrhagic events. Consequently, a TT test (an initial 'rule out' test) should be requested in order to promptly identify these patients. Moreover, discrepancies in derived and Clauss fibrinogen test results should suggest a functional disorder. Finally, new coagulation techniques based on the functional characterization of clot formation, such as ROTEM or thrombin generation assay, could help characterize these entities and suggest new therapeutic approaches.

LEARNING POINTS

Functional fibrinogen deficiencies can present with thrombotic manifestations only, and are a rare and probably underdiagnosed cause of thrombophilia.Thrombin time is a highly sensitive test to rule out other conditions as aPTT and PT results may be within normal ranges, especially in functional deficiencies.Discrepancies between derived and Clauss fibrinogen findings, fibrinogen protein measurements and the use of new techniques (ROTEM or thrombin generation) are important for correct approach.

摘要

未标注

纤维蛋白原缺乏症非常罕见。定性纤维蛋白原缺乏症(异常纤维蛋白原血症和低异常纤维蛋白原血症)是功能性疾病,可表现为出血症状和血栓形成现象,这是一种独特且矛盾的表现。我们报告一例77岁男性病例,该患者因腹主动脉瘤部分血栓形成接受检查,20年前曾发生缺血性中风。基础凝血试验正常,但进一步检查发现凝血酶时间(TT)延长,同时用Clauss法和比浊法测定的纤维蛋白原浓度显著下降。排除继发性纤维蛋白原缺乏症后,通过下一代测序检测到FGG基因中的杂合变异,诊断为先天性低异常纤维蛋白原血症。开始使用醋硝香豆素,随访一年后未发生新的血栓形成或出血事件。在近25%的病例中,血栓形成事件可能是功能性纤维蛋白原缺乏症的唯一临床表现。它们是血栓形成倾向的罕见原因,可能由于标准凝血试验结果正常以及可能没有出血事件而未被充分诊断。因此,应要求进行TT试验(初步“排除”试验),以便及时识别这些患者。此外,推导纤维蛋白原试验结果与Clauss纤维蛋白原试验结果之间的差异应提示存在功能性疾病。最后,基于凝块形成功能特征的新凝血技术,如旋转血栓弹力图(ROTEM)或凝血酶生成试验,有助于对这些疾病进行特征描述并提出新的治疗方法。

学习要点

功能性纤维蛋白原缺乏症可能仅表现为血栓形成表现,是血栓形成倾向的罕见且可能未被充分诊断的原因。凝血酶时间是一种高度敏感的试验,可排除其他情况,因为活化部分凝血活酶时间(aPTT)和凝血酶原时间(PT)结果可能在正常范围内,尤其是在功能性缺乏症中。推导纤维蛋白原结果与Clauss纤维蛋白原结果、纤维蛋白原蛋白测量值以及新技术(ROTEM或凝血酶生成)的使用之间的差异对于正确的诊断方法很重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验